1997
DOI: 10.1542/peds.99.6.765
|View full text |Cite
|
Sign up to set email alerts
|

Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States

Abstract: Preliminary design, data collection, and analytic capability of the Vaccine Safety Datalink project has been validated by replication of previous known associations between seizures and DTP and MMR vaccines. The diversity in vaccine administration schedules permits potential disentangling of effects of simultaneous and combined vaccinations. The project provides a model of public health-managed care collaborations in addition to an excellent infrastructure for safety and other studies of vaccines.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
149
0

Year Published

1998
1998
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 293 publications
(149 citation statements)
references
References 30 publications
0
149
0
Order By: Relevance
“…Therefore, enhanced post-marketing vaccine effectiveness, coverage, and safety surveillance is a critical component of any immunization program. [2][3][4] In Ontario, Canada's largest province (population 13.5 million with 142,448 births in 2013), 5 infant and toddler immunizations are almost exclusively administered through physician offices and funded under the Ontario Health Insurance Plan (OHIP). 6 Measles, mumps, rubella (MMR) and meningococcal conjugate serogroup C (MenC) vaccines are recommended at 12 months of age, while diphtheria, tetanus, acellular pertussis, inactivated polio, Haemophilus influenzae type B (DTaP-IPV-Hib) combination vaccine and pneumococcal conjugate vaccine (PC) are given at 2, 4, 6, and 18 months, and at 2, 4, and 12 months, respectively.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, enhanced post-marketing vaccine effectiveness, coverage, and safety surveillance is a critical component of any immunization program. [2][3][4] In Ontario, Canada's largest province (population 13.5 million with 142,448 births in 2013), 5 infant and toddler immunizations are almost exclusively administered through physician offices and funded under the Ontario Health Insurance Plan (OHIP). 6 Measles, mumps, rubella (MMR) and meningococcal conjugate serogroup C (MenC) vaccines are recommended at 12 months of age, while diphtheria, tetanus, acellular pertussis, inactivated polio, Haemophilus influenzae type B (DTaP-IPV-Hib) combination vaccine and pneumococcal conjugate vaccine (PC) are given at 2, 4, 6, and 18 months, and at 2, 4, and 12 months, respectively.…”
Section: Introductionmentioning
confidence: 99%
“…The study population included members of seven managed care organizations (MCOs) participating in the VSD project, a collaborative project between the CDC and eight MCOs established in 1991 to monitor and evaluate vaccine safety [2,3]. This project collects data on more than 8.8 million members annually including information on demographics, health plan enrollment, vaccinations, and medical encounters.…”
Section: Methodsmentioning
confidence: 99%
“…In particular, we suggest that the distributed data model-a secure means of collecting data from various sites that has been used successfully for quality measurement, vaccine surveillance, and other purposes-would be a desirable method of secure data collection. 12,14 Additionally, although the government and private sector have already made major investments in health information technology in the last few years, more dialogue and collaboration is necessary to build an information technology infrastructure ideally suited for measurement and reporting.…”
Section: Government As a Funder Of Scientific Researchmentioning
confidence: 99%